3
Announcements
Trials
Browse
Landscape
Sponsor
Conditions
Melanoma
23
Multiple Myeloma
9
Colorectal Neoplasms
9
Carcinoma, Non-Small-Cell Lung
9
Thyroid Neoplasms
8
Glioma
8
Neoplasm Metastasis
7
Hematologic Neoplasms
6
Thyroid Carcinoma, Anaplastic
5
Pancreatic Neoplasms
5
Lymphoma
5
Thyroid Cancer, Papillary
4
Neurofibromatosis 1
4
Neoplasms
4
Lung Neoplasms
3
Brain Neoplasms
3
Astrocytoma
3
Adenocarcinoma, Follicular
3
Skin Neoplasms
2
Recurrence
2
Rectal Neoplasms
2
Prostatic Neoplasms
2
Ovarian Neoplasms
2
Neurofibroma, Plexiform
2
Leukemia, Myelomonocytic, Juvenile
2
Histiocytosis, Langerhans-Cell
2
Glioblastoma
2
Colonic Neoplasms
2
Advanced Solid Tumors
2
Uveal Melanoma
1
Interventions
Specimen Handling
3
Oxaliplatin
3
Magnetic Resonance Spectroscopy
3
Fluorouracil
3
Radiosurgery
2
Liver Transplantation
2
Gemcitabine
2
Cisplatin
2
Biopsy
2
tislelizumab
1
sacituzumab govitecan
1
gemcitabine-oxaliplatin regimen
1
fludarabine
1
dehydroftorafur
1
binimetinib
1
Tegafur
1
S 1 (combination)
1
Pancreatic Hormones
1
Leucovorin
1
Hydroxychloroquine
1
Cyclophosphamide
1
Cholangiopancreatography, Endoscopic Retrograde
1
Capecitabine
1
3-(4-chlorophenyl)-adamantane-1-carboxylic acid (pyridin-4-ylmethyl)amide
1
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
0 trials
Recent
Start date
Enrollment
Klatskin Tumor
×
trametinib
×
1 year
×
Clear all
No trials found.